These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1982610)

  • 1. Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications.
    Haverkamp W; Gülker H; Hindricks G; Breithardt G
    Basic Res Cardiol; 1990; 85 Suppl 1():293-303. PubMed ID: 1982610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic action of beta-blockers: potential mechanisms.
    Dorian P
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S15-22. PubMed ID: 15965568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction.
    Adamson PB; Vanoli E; Hull SS; Foreman RD; Schwartz PJ
    Cardiovasc Res; 1998 Oct; 40(1):56-63. PubMed ID: 9876317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic properties of beta-blockers.
    Haverkamp W; Hindricks G; Gülker H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S29-32. PubMed ID: 11527133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic mechanisms and sudden death after abrupt coronary occlusion.
    Airaksinen KE
    Ann Med; 1999 Aug; 31(4):240-5. PubMed ID: 10480754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality reduction by antiadrenergic modulation of arrhythmogenic substrate: significance of combining beta blockers and amiodarone.
    Ogunyankin KO; Singh BN
    Am J Cardiol; 1999 Nov; 84(9A):76R-82R. PubMed ID: 10568664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S3-S14. PubMed ID: 15965570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long QT: good, bad or indifferent?
    Surawicz B; Knoebel SB
    J Am Coll Cardiol; 1984 Aug; 4(2):398-413. PubMed ID: 6145737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic blocking drugs as antifibrillatory agents.
    Reiter MJ
    Curr Cardiol Rep; 2002 Sep; 4(5):426-33. PubMed ID: 12169240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is drug therapy warranted to prevent sudden cardiac death?
    Singh BN
    Drugs; 1991; 41 Suppl 2():24-46. PubMed ID: 1711967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors.
    Lubbe WF; Podzuweit T; Opie LH
    J Am Coll Cardiol; 1992 Jun; 19(7):1622-33. PubMed ID: 1350597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
    Patterson E; Amalfitano DJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies.
    Pratt C; Lichstein E
    J Clin Pharmacol; 1982; 22(8-9):335-47. PubMed ID: 6127349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.